Search Results - "Pantò, F"

Enhanced performance of a PtCo recombination catalyst for reducing the H2 concentration in the O2 stream of a PEM electrolysis cell in the presence of a thin membrane and a high differential pressure by Briguglio, N., Pantò, F., Siracusano, S., Aricò, A.S.

“…High electrochemical efficiency at elevated current densities and low H2 concentration in O2 can be achieved in PEM electrolysis using thin membrane and…”
Get full text

Calving time identified by the automatic detection of tail movements and rumination time, and observation of cow behavioural changes by Giaretta, E., Marliani, G., Postiglione, G., Magazzù, G., Pantò, F., Mari, G., Formigoni, A., Accorsi, P.A., Mordenti, A.

“…The use of electronic devices to improve animal health, welfare and farm efficiency in precision livestock farming is a developing area of great scientific and…”
Get full text

No Phenotypic Differences for Polycystic Ovary Syndrome (PCOS) Between Women With and Without Type 1 Diabetes Mellitus by Amato, M. C, Guarnotta, V, Ciresi, A, Modica, R, Pantò, F, Giordano, C

“…Context: Women with type 1 diabetes mellitus (DM1) have a higher prevalence of polycystic ovary syndrome (PCOS) than the general population. Objective: The aim…”
Get full text

New Perspective to Improve Care of Patients with Infected Diabetic Foot Ulcer: Early Economic Impact of the Use of Photodynamic Therapy with RLP068 (Based) System by Lorenzoni, Valentina, Chiavetta, Agatina, Curci, Vincenzo, Pepa, Giuseppe Della, Licciardello, Carmelo, Pantò, Felicia, Scatena, Alessia, Turchetti, Giuseppe

“…To perform an early economic evaluation of a system based on photodynamic advanced adjuvant therapy with photosensitizer RLP068/CI to facilitate the healing…”
Get full text

Interleukin 2 and soluble interleukin 2-receptor secretion defect in vitro in newly diagnosed type I diabetic patients by Giordano, C., Panto, F., Caruso, C., Modica, M. A., Zambito, A. M., Sapienza, N., Amato, M. P., Galluzzo, A.

“…Interleukin 2 and soluble interleukin 2-receptor secretion defect in vitro in newly diagnosed type I diabetic patients. C Giordano , F Pantò , C Caruso , M A…”
Get full text

Prevalence of residual B-cell function related to age at onset and genetic profile in newly diagnosed type I diabetics by Giordano, C, Galluzzo, A, Pantò, F, Caruso, C, Bompiani, G

“…Patients with type I (insulin-dependent) diabetes mellitus maintain B-cell function for a varying period of time after onset. This is commonly held to account…”
Get full text

Interleukin 2 and soluble interleukin 2-receptor secretion defect in vitro in newly diagnosed type I diabetic patients by GIORDANO, C, PANTO, F, CARUSO, C, MODICA, M. A, ZAMBITO, A. M, SAPIENZA, N, AMATO, M. P, GALLUZZO, A

“…In this study, we investigated whether an interleukin 2 (IL-2) secretion defect by peripheral blood mononuclear cells (PBMCs) after in vitro stimulation with…”
Get full text

Study of T-cell activation in type I diabetic patients and pre-type I diabetic subjects by cytometric analysis : antigen expression defect in vitro by GIORDANO, C, DE MARIA, R, TODARO, M, STASSI, G, MATTINA, A, RICHIUSA, P, GALLUZZO, G, PANTO, F, GALLUZZO, A

“…In Type I diabetes the observation of a decreased release of interleukin-2 (IL-2) and soluble IL-2 receptors by means of stimulated lymphocytes in vitro…”
Get full text

Early administration of an immunomodulator and induction of remission in insulin-dependent diabetes mellitus by Giordano, C, Pantŏ, F, Amato, M P, Sapienza, N, Pugliese, A, Galluzzo, A

“…A clinical trial was undertaken to determine whether intensive thymopentin administration enhances remission of insulin-dependent diabetes (IDDM) during the…”
Get more information

Increased soluble interleukin-2 receptor levels in the sera of type 1 diabetic patients by Giordano, C, Galluzzo, A, Marco, A, Pantò, F, Amato, M P, Caruso, C, Bompiani, G D

“…Recently, the presence of a soluble form of IL-2 receptor (IL-2RS) in human sera and in supernatants of PHA-stimulated lymphocytes has been demonstrated. It…”
Get more information

The influence of high dose intravenous immunoglobulins on immunological and metabolic pattern in newly diagnosed type I diabetic patients by Pantŏ, F, Giordano, C, Amato, M P, Pugliese, A, Donatelli, M, D'Acquisto, G, Galluzzo, A

“…In autoimmune disease the functional deficiency of T suppressor cells, also described in Type I diabetes, may be restored through immunoglobulin (Ig) infusion,…”
Get more information

HLA-DR1 and HLA-DR3 phenotypes and insulin antibody production in diabetic Sicilian patients by Caruso, C, Giordano, C, Galluzzo, A, Pantò, F, Modica, M A

“…We have evaluated the role played by HLA antigens in the control of humoral response to exogenous insulin in a sample of Sicilian insulin-dependent diabetes…”
Get more information

Dissociated production of interleukin-2 and immune gamma-interferon by phytohaemoagglutinin stimulated peripheral mononuclear cells in type 1 (insulin-dependent) diabetes by Giordano, C, Caruso, C, Panto, F, Modica, M A, Zambito, A M, Amato, M P, Galluzzo, A

“…In order to analyze the first steps of T cell activation in type 1 diabetes we studied in vitro IL-2 and gamma-IFN production by peripheral blood mononuclear…”
Get more information

Study of T-cell activation in Type I diabetic patients and pre-Type I diabetic subjects by cytometric analysis: Antigen expression defectin vitro by Giordano, C., de Maria, R., Todaro, M., Stassi, G., Mattina, A., Richiusa, P., Galluzzo, G., Pantó, F., Galluzzo, A.

Get full text